Pieris Pharmaceuticals

$0.00 (0.00%) Today
$0.00 (0.00%) As of 8:02 PM UTC after-hours

Why Robinhood?

You can buy or sell PIRS and other stocks, options, and ETFs commission-free!

About PIRS

Pieris Pharmaceuticals, Inc. Common Stock, also called Pieris Pharmaceuticals, is a clinical-stage biotechnology company, which engages in the discovery and development of Anticalin-based drugs.

CEO
Stephen S. Yoder
Employees
123
Headquarters
Boston, Massachusetts
Founded
2001

PIRS Key Statistics

Market Cap
120.90M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
734.63K
High Today
$1.97
Low Today
$1.88
Open Price
$1.88
Volume
278.61K
52 Week High
$3.64
52 Week Low
$1.70

PIRS News

BenzingaMay 17

Pieris Pharmaceuticals: Q1 Earnings Insights

Shares of Pieris Pharmaceuticals (NASDAQ:PIRS) remained unaffected after the company reported Q1 results. Quarterly Results Earnings per share increased 0.00%

PIRS Earnings

-$0.28
-$0.20
-$0.13
-$0.05
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$0.17 per share
Actual
-$0.07 per share
Replay Earnings Call

You May Also Like

PZN
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure